Purpose: Study the effect of nepafenac ophthalmic suspension 0.1% to prevent post-operative cystoid macular edema following uncomplicated cataract surgery Participants: Patients having cataract surgery at UNC who meet eligibility criteria Procedures (methods): Patients will have pre and post-operative vision measured and optical coherence tomography (OCT) testing, also cataract density and intraoperative phacoemulsification parameters including ultrasound power and ultrasound time will be measured. Patients will be randomized into two groups. Group 1 will be treated with standard post-operative cataract management. Group 2 will be treated with standard post-operative cataract management plus topical nepafenac for one month. Post-operative macular thickness will be studied by analyzing the visual acuity and OCT measurements at two months post surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Central Macular Thickness (Difference in Mean Pre-post Changes by the Two Treatment Groups)
Timeframe: baseline and 8 weeks
Pre-operative Best Corrected Visual Acuity (BCVA)
Timeframe: baseline
Foveal Thickness
Timeframe: baseline and 8 weeks
Macular Volume (Difference in Mean Pre-post Changes by the Two Treatment Groups)
Timeframe: baseline and 8 weeks
Post-operative Best Corrected Visual Acuity (BCVA)
Timeframe: baseline and 8 weeks